cotinine | 			
(-)-Cotinine | 
				
486-56-6 | 			
(S)-Cotinine | 
				
Cotinina | 			
Cotininum | 
				
(S)-(-)-Cotinine | 			
(5S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one | 
				
Cotinine (-) | 			
(S)-1-methyl-5-(pyridin-3-yl)pyrrolidin-2-one | 
				
2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (5S)- | 			
UNII-K5161X06LL | 
				
(S)-1-Methyl-5-(3-pyridinyl)-2-pyrrolidinone | 			
NIH 10498 | 
				
(5S)-1-methyl-5-pyridin-3-ylpyrrolidin-2-one | 			
Nicotine related compound c | 
				
CHEBI:68641 | 			
(S)-1-Methyl-5-(3-pyridyl)-2-pyrrolidinone | 
				
K5161X06LL | 			
MFCD00077696 | 
				
S-(-)-Cotinine | 			
S(-)-1-Methyl-5-(3-pyridyl)-2-pyrrolidone | 
				
(5S)-1-methyl-5-(3-pyridyl)pyrrolidin-2-one | 			
DSSTox_CID_27576 | 
				
DSSTox_RID_82428 | 			
DSSTox_GSID_47576 | 
				
BRD4010 | 			
BRD-4010 | 
				
Cotinine INN | 			
SMR000449278 | 
				
Cotininum INN-Latin | 			
SR-01000075768 | 
				
Cotinina INN-Spanish | 			
CCRIS 7625 | 
				
HSDB 7805 | 			
NCGC00093739-04 | 
				
(5S)-1-methyl-5-(3-pyridinyl)-2-pyrrolidinone | 			
CAS-486-56-6 | 
				
Prestwick_134 | 			
EINECS 207-634-9 | 
				
BRN 0083099 | 			
Spectrum_001984 | 
				
Nicotine EP Impurity C | 			
Prestwick0_000082 | 
				
Prestwick1_000082 | 			
Prestwick2_000082 | 
				
Prestwick3_000082 | 			
Spectrum3_000700 | 
				
Spectrum4_001793 | 			
Spectrum5_000465 | 
				
NICOTINE IMPURITY C | 			
bmse000577 | 
				
(-)-Cotinine, 98% | 			
Lopac0_000285 | 
				
SCHEMBL49060 | 			
BSPBio_000004 | 
				
BSPBio_002459 | 			
KBioGR_002368 | 
				
KBioSS_002550 | 			
5-24-02-00504 (Beilstein Handbook Reference) | 
				
MLS000758262 | 			
MLS001423950 | 
				
DivK1c_000861 | 			
SPECTRUM1500208 | 
				
SPBio_001943 | 			
(-)-Cotinine, >=98% | 
				
BPBio1_000006 | 			
CHEMBL578211 | 
				
MEGxp0_001870 | 			
DTXSID1047576 | 
				
ACon1_000202 | 			
KBio1_000861 | 
				
KBio2_002541 | 			
KBio2_005109 | 
				
KBio2_007677 | 			
KBio3_001679 | 
				
NINDS_000861 | 			
US8609708, 91 Cotinine | 
				
HMS1568A06 | 			
HMS1920A14 | 
				
HMS2051A15 | 			
HMS2091G22 | 
				
HMS2095A06 | 			
HMS2232F15 | 
				
HMS3260J12 | 			
Pharmakon1600-01500208 | 
				
ZINC402766 | 			
(-)-Cotinine, analytical standard | 
				
HY-B1178 | 			
Tox21_111219 | 
				
Tox21_300615 | 			
Tox21_500285 | 
				
4205AE | 			
BBL102262 | 
				
BDBM50370573 | 			
NIH-10498 | 
				
NSC756704 | 			
s9339 | 
				
STL556061 | 			
AKOS007930814 | 
				
Tox21_111219_1 | 			
(-)-Cotinine 1.0 mg/ml in Methanol | 
				
CCG-100799 | 			
CS-4787 | 
				
LP00285 | 			
MCULE-8421169764 | 
				
NC00049 | 			
NSC-756704 | 
				
SDCCGMLS-0066565.P001 | 			
SDCCGSBI-0050273.P004 | 
				
IDI1_000861 | 			
NCGC00093739-08 | 
				
NCGC00093739-13 | 			
NCGC00093739-20 | 
				
NCGC00254396-01 | 			
NCGC00260970-01 | 
				
AS-50387 | 			
ST057157 | 
				
SBI-0050273.P003 | 			
AM20061246 | 
				
B7277 | 			
EU-0100285 | 
				
(-)-Cotinine 100 microg/mL in Acetonitrile | 			
C 5923 | 
				
P10066 | 			
AB00053721_08 | 
				
(5S)-1-methyl-5-pyridin-3-yl-pyrrolidin-2-one | 			
A827581 | 
				
Q421177 | 			
SR-01000075768-1 | 
				
SR-01000075768-5 | 			
SR-01000075768-6 | 
				
BRD-K94144010-001-04-8 | 			
BRD-K94144010-001-05-5 | 
				
BRD-K94144010-001-09-7 | 			
(-)-Cotinine solution, drug standard, 1.0 mg/mL in methanol | 
				
2-Pyrrolidinone, 1-methyl-5-(3-pyridinyl)-, (S)- (9CI) | 			
(5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one ((-)-Cotinine) | 
				
(-)-Cotinine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material | 			
Nicotine Related Compound C, United States Pharmacopeia (USP) Reference Standard | 
				
Cotinine; Nicotine USP Related Compound C; (5S)-1-Methyl-5-(pyridin-3-yl)pyrrolidin-2-one; (S)-(-)-1-Methyl-5-(3-pyridiyl)-2- pyrrolidinone | 			
 |